Literature DB >> 10750213

Antimicrobial agents in lower respiratory tract infections in Dutch general practice.

M M Kuyvenhoven1, T J Verheij, R A de Melker, J van der Velden.   

Abstract

This study describes the prescription of antimicrobial agents in cases of lower respiratory tract infections in Dutch general practice. A secondary analysis of data from the National Study of Illness and Procedures of The Netherlands Institute of Primary Health Care (a nationwide group of 161 general practitioners with data from 334,449 patients) had been carried out. Antimicrobial agents were prescribed in 30% of all contacts: in about half of the first contacts and contacts for recurrences, and in one out of six repeat contacts. The prescription rates were associated with diagnosis and reason for encounter but rarely with older age or comorbidity. Amoxycillin and doxycycline were most frequently prescribed. While most lower respiratory tract infections are virus-induced and antibiotics are not effective in most cases, antimicrobial agents might still be overprescribed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10750213      PMCID: PMC1313633     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  8 in total

1.  Antibiotics for respiratory tract symptoms in general practice.

Authors:  T Fahey
Journal:  Br J Gen Pract       Date:  1998-12       Impact factor: 5.386

2.  Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the U.K.: implications for developing management guidelines.

Authors:  J Macfarlane; S A Lewis; R Macfarlane; W Holmes
Journal:  Respir Med       Date:  1997-08       Impact factor: 3.415

Review 3.  Strategies for promoting judicious use of antibiotics by doctors and patients.

Authors:  E A Belongia; B Schwartz
Journal:  BMJ       Date:  1998-09-05

Review 4.  [Efficacy of antibiotics in frequently occurring airway infections in family practice].

Authors:  R A de Melker
Journal:  Ned Tijdschr Geneeskd       Date:  1998-02-28

Review 5.  Reducing antibiotics for respiratory tract symptoms in primary care: consolidating 'why' and considering 'how'.

Authors:  C C Butler; S Rollnick; P Kinnersley; A Jones; N Stott
Journal:  Br J Gen Pract       Date:  1998-12       Impact factor: 5.386

6.  Management of upper respiratory tract infections in Dutch family practice.

Authors:  R A de Melker; M M Kuyvenhoven
Journal:  J Fam Pract       Date:  1994-04       Impact factor: 0.493

7.  Effects of doxycycline in patients with acute cough and purulent sputum: a double blind placebo controlled trial.

Authors:  T J Verheij; J Hermans; J D Mulder
Journal:  Br J Gen Pract       Date:  1994-09       Impact factor: 5.386

8.  Treatment of acute bronchitis in adults. A national survey of family physicians.

Authors:  K C Oeffinger; L M Snell; B M Foster; K G Panico; R K Archer
Journal:  J Fam Pract       Date:  1998-06       Impact factor: 0.493

  8 in total
  10 in total

1.  Antibiotic prescribing in primary care: first choice and restrictive prescribing are two different traits.

Authors:  M S van Roosmalen; J C C Braspenning; P A G M De Smet; R P T M Grol
Journal:  Qual Saf Health Care       Date:  2007-04

2.  Antibiotic prescribing and C-reactive protein testing for pulmonary infections in patients with intellectual disabilities.

Authors:  Catharina M Peters; Francesca M Schouwenaars; Ellen Haagsma; Heleen M Evenhuis; Michael A Echteld
Journal:  Br J Gen Pract       Date:  2013-05       Impact factor: 5.386

3.  Prescribing antibiotics for respiratory tract infections by GPs: management and prescriber characteristics.

Authors:  Annemiek E Akkerman; Marijke M Kuyvenhoven; Johannes C van der Wouden; Theo J M Verheij
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

4.  Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection.

Authors:  R M Hopstaken; J W Muris; J A Knottnerus; A D Kester; P E Rinkens; G J Dinant
Journal:  Br J Gen Pract       Date:  2003-05       Impact factor: 5.386

5.  One hundred coughs: family practice case series.

Authors:  Graham J Worrall
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

6.  Public beliefs on antibiotics and respiratory tract infections: an internet-based questionnaire study.

Authors:  Jochen W L Cals; Dennis Boumans; Robert J M Lardinois; Ralph Gonzales; Rogier M Hopstaken; Christopher C Butler; Geert-Jan Dinant
Journal:  Br J Gen Pract       Date:  2007-12       Impact factor: 5.386

7.  Matching diagnostics development to clinical need: Target product profile development for a point of care test for community-acquired lower respiratory tract infection.

Authors:  Micaela Gal; Nicholas A Francis; Kerenza Hood; Jorge Villacian; Herman Goossens; Angela Watkins; Christopher C Butler
Journal:  PLoS One       Date:  2018-08-01       Impact factor: 3.240

8.  Prescribing Patterns for Upper Respiratory Tract Infections: A Prescription-Review of Primary Care Practice in Quetta, Pakistan and the Implications.

Authors:  Hania Hashmi; Nazeer Ahmad Sasoli; Abdul Sadiq; Abdul Raziq; Fakhra Batool; Shanaz Raza; Qaiser Iqbal; Sajjad Haider; Syed Umer Jan; Muhammad Alam Mengal; Abdul Malik Tareen; Adnan Khalid; Fahad Saleem
Journal:  Front Public Health       Date:  2021-11-19

9.  Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial.

Authors:  Jochen W L Cals; Christopher C Butler; Rogier M Hopstaken; Kerenza Hood; Geert-Jan Dinant
Journal:  BMJ       Date:  2009-05-05

10.  Diagnostic labelling as determinant of antibiotic prescribing for acute respiratory tract episodes in general practice.

Authors:  Huug J van Duijn; Marijke M Kuyvenhoven; Hanneke M Tiebosch; François G Schellevis; Theo J M Verheij
Journal:  BMC Fam Pract       Date:  2007-09-20       Impact factor: 2.497

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.